ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Anita Agrawal, Rajni Chibbar, Anahita Safavi-Naini
Objective: To describe the primary carcinoma of the retroperitoneum that was positive for human papillomavirus (HPV), a surrogate molecular marker for high-risk HPV (p16) and p53. Methods: This is a case report. Results: We report a case of 50-year - old woma…
Qun Fan, Xinhui Su, Anren Kuang
Objective: The aim of this retrospective study was to evaluate diagnostic accuracy of serum thyroglobulin antibody (TgAb) in thyroglobulin (Tg)-negative and TgAb-positive (Tg - TgAb + ) patients with differentiated thyroid carcinoma (DTC). Method: We studied…
Matthew Smith-Cohn, Zhijian Chen, David Peereboom, Glen Stevens
After surgical resection, patients with glioblastoma require many aspects of care to maximize function and quality of life. Patients face a multitude of hurdles that require the expertise of a variety of specialists. Here we will review the current literature…
Nadja Seidel, Friederike Stoelzel, Sandra Herrmann, Cornelia Zimmermann, Hendrik Berth, Melanie Glausch, Kristina Loewe, Michael Baumann, Gerhard Ehninger
At least one third of all newly diagnosed cancers could be prevented if lifestyle factors were changed. The University Cancer Center Dresden initiated two programs aiming at cancer awareness and intentions to engage in health-promoting behavior among children…
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski
Nonresectable Low-Grade Astrocytomas (LGA) can compromise function and threaten life. For the majority of patients, the most appropriate strategy is initial chemotherapy followed by Radiation Therapy (RT). Since curative treatment is not available for most of…
Upendra Parvathaneni, Madhu Shetti, Daniel Berg, Seesha Takagishi, George E. Laramore, Chrysalyne D. Schmults, Anokhi Jambusaria-Pahlajani, Stephen D. Hess, Marvin Heyboer III, Jay J. Liao
Purpose: Post-operative radiotherapy (PORT) for resected cutaneous squamous cell carcinoma (CSCC) with perineural invasion (PNI) is controversial. Therefore, we conducted a survey to review treatment recommendations among Radiation Oncologists (ROs) in the ma…
Smaila Ouédraogo, Nayi Zongo, Nina Korsaga-Somé, Seraphine Marie Suzanne Kaboré, Edgar Ouangré, Maurice Zida, A. S. Ouédraogo, Aboubacar Hierrum Bambara, Augustin Touzoula Bambara, Si Simon Traoré, Pascal Niamba, Adama Traoré, Ahmadou Dem
The objective is to s tudy the knowledge that albinos have on skin cancers, and their attitudes in terms of primary prevention and the screening practices for skin cancers in Burkina Faso. Methods: This is a cross-sectional and descriptive KAP study conducted…
John J. Wille, Jong Y. Park
The effect s of growth factors and calcium concentrations present in different culture media on induction of terminal differentiation were investigated for four different epidermoid carcinoma cell lines, Hela, KB, A431, and SCC - 25, and their responses deter…
Wolfram E. Samlowski, Joseph Wojcik, Suzanne Samlowski, Douglas Fife, Todd Murry
Atypical fibroxanthoma s (AFX) are rare skin tumors. These generally are superficial tumors, usually <3 cm red, fleshy, ulcerated skin lesions, that characteristically occur on sun-damaged skin, sometimes in immunocompromised or previously irradiated patients…
A. S. Koné, A. Diakité, S. Ahid, I. M. Diarra, K. Diabaté, R. Abouqal, Y. Cherrah, N. Benjaafar
Hypofraction at ed radiation therapy has proven effective on locoregional control and tolerance in the adjuvant treatment of breast cancer. The aim of this study is to compare the results of hypofractionated radiation therapy versus conventional radiation the…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).